URGN
UroGen Pharma Ltd
41.60$
-2.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 11.4% | 9.7% | 9.2% | 10.2% | 9.7% | 10.1% | 11.5% | 14.7% | 11.9% | 8.7% | 8.1% | 9.1% | 9.2% | |
| 88.6% | 90.3% | 90.8% | 89.8% | 90.3% | 89.9% | 88.5% | 85.3% | 88.1% | 91.3% | 91.9% | 90.9% | 90.8% | |
| 49.1% | 48.0% | 82.5% | 70.5% | 45.1% | 60.6% | 98.1% | 78.1% | 51.0% | 37.8% | 30.6% | 23.9% | 32.5% | |
| 104.3% | 104.3% | 145.4% | 137.6% | 114.8% | 141.9% | 172.6% | 178.4% | 136.8% | 104.0% | 101.0% | 66.9% | 93.7% | |
| 153.4% | 152.4% | 227.9% | 208.1% | 159.9% | 202.5% | 270.8% | 256.5% | 187.7% | 141.8% | 131.6% | 90.8% | 126.2% | |
| -64.7% | -62.1% | -137.1% | -118.3% | -69.6% | -112.6% | -182.3% | -171.2% | -99.7% | -50.5% | -39.8% | 0.2% | -35.3% | |
| 18.3% | 15.2% | 13.0% | 15.8% | 10.8% | 15.8% | 20.1% | 36.2% | 29.1% | 34.4% | 17.1% | 6.7% | 18.3% | |
| -105.0% | -94.2% | -171.6% | -152.7% | -93.6% | -141.9% | -214.5% | -202.0% | -125.2% | -70.4% | -55.6% | -12.0% | -52.0% | |
| 0.0% | 16.4% | 0.3% | 0.2% | 0.4% | 10.8% | 1.9% | 4.2% | -3.8% | -0.7% | -9.4% | 7.8% | -0.3% | |
| -104.9% | -110.6% | -171.9% | -152.9% | -93.9% | -152.7% | -216.5% | -206.2% | -121.3% | -69.7% | -46.3% | -19.8% | -51.7% | |
| -58.4% | -31.5% | -126.6% | -135.7% | -58.2% | -107.8% | -192.0% | -201.6% | -93.8% | -58.6% | -37.3% | -5.2% | -37.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.